Pharmaceutical Cold Chain Logistics Market to Reach US$27.11 Billion by 2033 | Transportation Leads with 58% Share | North America Dominates at 42.9% | DataM Intelligence

Leander, Texas- The Global Pharmaceutical Cold Chain Logistics Market Size reached US$18.61 Billion in 2024 and is expected to reach US$27.11 Billion by 2033, growing at a CAGR of 4.3% during the forecast period 2025-2033, according to DataM Intelligence report. Growth is driven by Rising demand for temperature-sensitive drugs and vaccines, coupled with strict regulatory compliance, drives cold chain logistics growth.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/pharmaceutical-cold-chain-logistics-market?pratik

🔹 United states industry development
⇥ Market size: Approximately USD 18.61 billion in 2024, growing at a CAGR of about 6-7%.

⇥ 2025: Rising demand for biologics and vaccines drives adoption of automated cold storage and cryogenic packaging technologies.

⇥ 2025: Launch of scalable reusable pallet shippers and advanced freezing equipment enhances pharmaceutical cold chain efficiency.

🔹 Japan industry development
⇥ Market size: Around USD 5.0 billion in 2024, projected to grow at a CAGR of about 10.3%.

⇥ 2025: Japan focuses on compact, energy-efficient freeze-drying and cold storage solutions, supported by government regulatory reforms and infrastructure investments.

⇥ 2025: Infrastructure improvements including refrigerated hubs and drone deliveries reduce cold chain delivery times significantly.

⇥ 2025: Companies investing in AI and IoT for real-time supply chain monitoring and operational optimization.

🔹 Market segmentation with Market share -

➠ By Product

Vaccines dominate with approximately 50% market share, reflecting high demand for temperature-sensitive immunizations.

Biopharmaceuticals (including biologics and gene therapies) account for about 30%, driven by complex storage needs at ultra-low temperatures.

Clinical trial materials represent around 10%, requiring reliable cold chain to ensure trial integrity.

Other pharmaceutical products make up the remaining 10%, including specialized drugs requiring refrigerated transport.

➠ By Service

Transportation holds the largest share at about 58%, encompassing refrigerated road, air, and sea freight solutions critical for time-sensitive deliveries.

Warehousing and value-added services (VAS) represent 35%, including GMP-compliant storage, packaging, and temperature monitoring.

Packaging and other ancillary services comprise roughly 7%, focused on advanced insulated and active packaging technologies.

➠ By Temperature Range

Refrigerated (2°C to 8°C) dominates at 45%, suitable for most vaccines and injectables.

Frozen (Below -20°C) accounts for 24%, important for frozen biologics and mRNA vaccines.

Cryogenic (-150°C and below) holds 20%, primarily for cell and gene therapies needing ultra-low preservation.

Ambient (15°C to 25°C) makes up 11%, for non-temperature sensitive pharmaceutical products.

"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=pharmaceutical-cold-chain-logistics-market?pratik ((Purchase 2 or more Repots and get 50% Discount)

🔹 Regional insights-

➠ North America:

The largest regional market, with approximately 42.9% share in 2024.

Growth is driven by a mature biotech and biopharmaceutical industry, high demand for biologics, vaccines, and ultra‐low temperature therapies.

Leading logistics providers are investing heavily in technology - IoT-enabled temperature monitoring, automated cold-storage warehouses, and cryogenic packaging solutions.

➠ Asia‐Pacific:

A fast-growing region: according to Strategic Revenue Insights, the Pharma Cold Chain Logistics market in Asia-Pacific has a projected CAGR of 9.2%

In the APAC Pharmaceutical cold chain logistics market , China accounted for 39% of the regional share in 2024, while India is expected to grow fast (CAGR 6.1% to 2030).
➠ Europe:

A mature market with steady growth: per healthcare cold chain reports, Europe accounted for ~28.7% of the cold chain logistics (healthcare) market in 2024

There is a strong push toward sustainability: European cold-chain providers increasingly use eco‐friendly refrigerants, energy-efficient storage, and "green" logistics

🔹 Emerging players :-

⇥ Americold Logistics holds about 15% market share; strong in refrigerated warehousing and distribution with advanced automation and AI for efficiency.

⇥ Lineage Logistics commands around 12%; leads in temperature-controlled warehousing with IoT and AI, expanding globally via acquisitions.

⇥ DHL International GmbH has 10%; invests in pharma specialized networks and end-to-end cold chain solutions via strategic partnerships and acquisitions.

⇥ United Parcel Service (UPS) owns 8%; offers global temperature-controlled shipping, real-time monitoring, and AI analytics for pharma logistics.

⇥ FedEx Corporation controls 7%; extensive global logistics network with innovative temperature-controlled packaging ensuring compliance and reliability.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/pharmaceutical-cold-chain-logistics-market?pratik

🔹 Key Investment:

➠ DHL International GmbH (Germany): Acquired CRYOPDP, a specialty courier focused on clinical trials and biopharma, in March 2025, enhancing pharma logistics capabilities with an estimated investment of over USD 100 million.

➠ United Parcel Service (UPS) (U.S.): Acquired German healthcare cold-chain logistics providers Frigo-Trans and BPL in early 2025, and Canada's Andlauer Healthcare Group (AHG) in April 2025 for USD 1.6 billion, expanding temperature-controlled storage and distribution networks.

➠ Cold Chain Technologies (CCT) (U.S.): Launched advanced reusable temperature-controlled pallet shipper and new product lines in 2025 with significant R&D and market investments to innovate shipping solutions.

➠ Lineage Logistics (U.S.): Invested heavily in expanding refrigerated warehouses and green infrastructure in 2025, targeting a rapidly growing pharma cold chain demand with multi-million dollar capital deployments.

🔹 Growth Drivers:-

Rising demand for temperature-sensitive biologics, vaccines, gene therapies, and specialty medicines fuels market expansion.

Global immunization programs and pandemic preparedness increase the need for reliable cold chain logistics.

Increasing globalization of clinical trials and biopharmaceutical trade demands end-to-end cold chain continuity.

Regulatory mandates like FDA's Drug Supply Chain Security Act require stringent temperature control and real-time tracking.

Technology advancements in IoT, AI, GPS tracking, telematics, and active packaging improve supply chain visibility and compliance.

Growing investments in refrigerated transport fleets, automated warehouses, and advanced cold storage infrastructure.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.